Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico

被引:83
作者
Diaz, E
Mondragon, J
Ramirez, E
Bernal, R
机构
[1] Hosp Infantil Mexico Fed Gomez, Secretaria Salubridad & Asistencia, Lab Parasitol & Micol, Mexico City 06720, DF, Mexico
[2] Inst Mexicano Seguro Social, Unidad Med Familiar 91, Coacalco De Berriozabal 55700, Estado Mexico, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Dept Ciencias Quim, Cuautitlan, Estado Mexico, Mexico
[4] Hosp Infantil Mexico Dr Federico Gomez, Lab Parasitol & Micol, Mexico City 06720, DF, Mexico
关键词
D O I
10.4269/ajtmh.2003.68.384
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The purpose of this study was to evaluate the efficacy and the tolerance of nitazoxanide in children as a single broad-spectrum antiparasitic agent in the treatment of mixed parasite infections with both intestinal protozoa and helminths. Two hundred seventy-two children (age range 2-14 years) participated in this study. We systematically surveyed every household head using questionnaires designed to obtain information about household socioeconomic status and hygiene. Parasitic infections were confirmed by three stool examinations using direct smear, Ferreira concentration, and cold acid-fast Kinyoun staining methods. One hundred twenty-one (44%) children tested positive for protozoa such as Giardia lamblia (18%), Entamoeba histolytica/E. dispar (10%), Blastocystis hominis (7%), Cryptosporidium parvum (4%), and Cyclospora cayetanensis (3%), and helminths such as Hymenolepis nana (10%), Trichuris trichiura (6%), and Ascaris lumbricoides (6%). There were also two cases of infection with Enterobius vermicularis. After a complete physical examination was performed, 121 patients received treatment with nitazoxanide. Overall, 84% of the protozoa and 95% of the helminths were completely eliminated from the patients. Nitazoxanide was very well tolerated, with no serious adverse effects reported.
引用
收藏
页码:384 / 385
页数:2
相关论文
共 10 条
[1]   Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: A report on 546 patients in Egypt [J].
Abaza, H ;
El-Zayadi, AR ;
Kabil, SM ;
Rizk, H .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (02) :116-121
[2]   COMPARISON OF METHODS OF EXAMINING STOOLS FOR PARASITES [J].
BIAGI, F ;
PORTILLA, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1957, 6 (05) :906-911
[3]   Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa [J].
Doumbo, O ;
Rossignol, JF ;
Pichard, E ;
Traore, HA ;
Dembele, M ;
Diakite, M ;
Traore, F ;
Diallo, DA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (06) :637-639
[4]  
GARCIA L, 1997, P RECOVERY IDENTIFIC, V17, P8
[5]  
HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594
[6]   Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru [J].
Ortiz, JJ ;
Ayoub, A ;
Gargala, G ;
Chegne, NL ;
Favennec, L .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) :1409-1415
[7]  
ROMERO CR, 1997, T ROY SOC TROP MED H, V91, P701
[8]   Successful treatment of human fascioliasis with nitazoxanide [J].
Rossignol, JF ;
Abaza, H ;
Friedman, H .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (01) :103-104
[9]   NITAZOXANIDE IN THE TREATMENT OF TAENIA-SAGINATA AND HYMENOLEPIS-NANA INFECTIONS [J].
ROSSIGNOL, JF ;
MAISONNEUVE, H .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (03) :511-512
[10]  
Rossignol JF., 1975, CHEM ABSTR, V83